Kidney Force
Natural health product licensed in Canada
- Other names
- Enoch Natural Kidney Force, Enoch Kidney Force
- Licence holder
- Enoch Nutrition Research Development Inc.
- NPN or DIN-HM
- 80073343
- Status
- Active licence
- Licence date
- 28 October 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Arctium lappa Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 milligramme | 40 milligramme | Not calculated |
| Nelumbo nucifera Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 60 milligramme | 7.5 milligramme | Not calculated |
| Phellodendron chinense Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50 milligramme | Not calculated |
| Zea mays Source : Stigmates Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 milligramme | 40 milligramme | Not calculated |
| Rehmannia glutinosa Source : Tubercule Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 milligramme | 40 milligramme | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 milligramme | 40 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 30 milligramme | Not calculated |
| Dioscorea oppositifolia Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 milligramme | 40 milligramme | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 milligramme | 80 milligramme | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 milligramme | 80 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Arctostaphylos uva-ursi is Traditionally used in Herbal Medicine as a mild diuretic to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination. Used in Herbal Medicine to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. Do not use if you are pregnant or breastfeeding. If you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine, consult a health care practitioner prior to us. Consult a health care practitioner prior to use if you have diabetes. Store in a cool, dry place. If you are taking prescription medications, consult a health care practitioner prior to use. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Source
Official Health Canada record, licence 80073343
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.